When Do We Need CNS Prophylaxis in Patients with Extranodal NK/T Cell Lymphoma?
Oral and Poster Abstracts Poster Session: Non-Hodgkins Lymphoma – Biology, Excluding Therapy Poster II Sunday, December 7, 2008, 6:00 PM-8:00 PM Hall A (Moscone Center) Poster Board II-927 Seok Jin Kim, MD, PhD1, Sung Hyun Kim, MD, PhD2, Jooryung Huh, MD3*, Young-Hyeh Ko, MD4*, Hyo-Jin Kim5*, Cheolwon Suh, MD6 and Won Seog Kim1*1Medicine, Samsung Med. Ctr., Seoul, South Korea 2Dept. of Hem.-Onc., Internal Med., Dong-A University Hospital, Pusan, South Korea 3Department of Pathology, Asan medical center, University of Ulsan College of Medicine, Seoul, South Korea 4Pathology, Samsung Medical Center, Seoul, South Korea 5Dept. of Hem.-Onc., Internal Med., Dong-A University Hospital, Busan, South Korea 6Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Purpose: Extranodal natural killer (NK)/T cell lymphoma, nasal type frequently involves paranasal sinuses. Although involvement of the paranasal sinuses has been regarded as a possible ri
